Working… Menu

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02842138
Recruitment Status : Unknown
Verified February 2019 by Jun Zhu, Peking University.
Recruitment status was:  Active, not recruiting
First Posted : July 22, 2016
Last Update Posted : February 25, 2019
Marino Biotechnology Co., Ltd.
Information provided by (Responsible Party):
Jun Zhu, Peking University